BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10666516)

  • 1. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability.
    Crain SM; Shen KF
    Pain; 2000 Feb; 84(2-3):121-31. PubMed ID: 10666516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
    Crain SM; Shen KF
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.
    Shen KF; Crain SM
    Brain Res; 2001 Nov; 919(1):20-30. PubMed ID: 11689159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
    Crain SM; Shen KF
    Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture.
    Shen KF; Crain SM
    Brain Res; 1995 Dec; 701(1-2):158-66. PubMed ID: 8925279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence.
    Crain SM; Shen KF
    Neurochem Res; 1996 Nov; 21(11):1347-51. PubMed ID: 8947924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
    Shen KF; Crain SM
    Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions.
    Crain SM; Shen K
    Brain Res; 2000 Feb; 856(1-2):227-35. PubMed ID: 10677630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
    Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
    Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
    Crain SM; Shen KF
    Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of 'protracted opioid dependence'.
    Crain SM; Shen KF
    Brain Res; 1995 Oct; 694(1-2):103-10. PubMed ID: 8974633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neonatal rat morphine tolerance and dependence.
    Thornton SR; Wang AF; Smith FL
    Eur J Pharmacol; 1997 Dec; 340(2-3):161-7. PubMed ID: 9537810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.